Literature DB >> 7574193

Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study.

J C Peterson, S Adler, J M Burkart, T Greene, L A Hebert, L G Hunsicker, A J King, S Klahr, S G Massry, J L Seifter.   

Abstract

OBJECTIVE: To examine the relations among proteinuria, prescribed and achieved blood pressure, and decline in glomerular filtration rate in the Modification of Diet in Renal Disease Study.
DESIGN: 2 randomized trials in patients with chronic renal diseases of diverse cause.
SETTING: 15 outpatient nephrology practices at university hospitals. PATIENTS: 840 patients, of whom 585 were in study A (glomerular filtration rate, 25 to 55 mliters/min.1.73 m2) and 255 were in study B (glomerular filtration rate, 13 to 24 mliters/min.1.73 m2). Diabetic patients who required insulin were excluded.
INTERVENTIONS: Patients were randomly assigned to a usual blood pressure goal (target mean arterial pressure, < or = 107 mm Hg for patients < or = 60 years of age and < or = 113 mm Hg for patients > or = 61 years of age) or a low blood pressure goal (target mean arterial pressure, < or = 92 mm Hg for patients < or = 60 years of age and < or = 98 mm Hg for patients > or = 61 years of age). MAIN OUTCOME MEASURES: Rate of decline in glomerular filtration rate and change in proteinuria during follow-up.
RESULTS: The low blood pressure goal had a greater beneficial effect in persons with higher baseline proteinuria in both study A (P = 0.02) and study B (P = 0.01). Glomerular filtration rate declined faster in patients with higher achieved blood pressure during follow-up in both study A (r = -0.20; P < 0.001) and study B (r = -0.34; P < 0.001), and these correlations were stronger in persons with higher baseline proteinuria (P < 0.001 in study A; P < 0.01 in study B). In study A, the association between decline in glomerular filtration rate and achieved follow-up blood pressure was nonlinear (P = 0.011) and was stronger at higher mean arterial pressure. In both studies, the low blood pressure goal significantly reduced proteinuria during the first 4 months after randomization. This, in turn, correlated with a slower subsequent decline in glomerular filtration rate.
CONCLUSIONS: Our study supports the concept that proteinuria is an independent risk factor for the progression of renal disease. For patients with proteinuria of more than 1 g/d, we suggest a target blood pressure of less than 92 mm Hg (125/75 mm Hg). For patients with proteinuria of 0.25 to 1.0 g/d, a target mean arterial pressure of less than 98 mm Hg (about 130/80 mm Hg) may be advisable. The extent to which lowering blood pressure reduces proteinuria may be a measure of the effectiveness of this therapy in slowing the progression of renal disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7574193     DOI: 10.7326/0003-4819-123-10-199511150-00003

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  277 in total

1.  Additive antiproteinuric effect of ACE inhibitor and losartan in IgA nephropathy.

Authors:  Rakesh Bhattacharjee; G Filler
Journal:  Pediatr Nephrol       Date:  2002-04       Impact factor: 3.714

Review 2.  Is normotension good enough for the patient with type 2 diabetes?

Authors:  E Ritz; M Schömig
Journal:  Curr Hypertens Rep       Date:  1999-10       Impact factor: 5.369

Review 3.  Hypertension: goal systolic and diastolic blood pressure.

Authors:  M R Weir
Journal:  Curr Hypertens Rep       Date:  1999-10       Impact factor: 5.369

Review 4.  Rationale for the use of a fixed-dose combination in the management of hypertension: efficacy and tolerability of lercanidipine/enalapril.

Authors:  Claudio Borghi; Arrigo F G Cicero
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

Review 5.  Can vitamin D slow down the progression of chronic kidney disease?

Authors:  Rukshana Shroff; Mandy Wan; Lesley Rees
Journal:  Pediatr Nephrol       Date:  2011-12-10       Impact factor: 3.714

Review 6.  Antihypertensive drugs and the kidney.

Authors:  Mitra K Nadim; Renee Dua; Vito M Campese
Journal:  Curr Cardiol Rep       Date:  2004-11       Impact factor: 2.931

Review 7.  Blood pressure control--effects on diabetic nephropathy progression: how low does blood pressure have to be?

Authors:  Christopher A Newton; Philip Raskin
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

Review 8.  [Protection of renal function in diabetics].

Authors:  C Hasslacher
Journal:  Internist (Berl)       Date:  2007-07       Impact factor: 0.743

Review 9.  Angiotensin II and the glomerulus: focus on diabetic kidney disease.

Authors:  James W Scholey
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

Review 10.  Appropriate drug therapy for improving outcomes in diabetic nephropathy.

Authors:  Robert D Toto
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.